MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00277-011-1387-9

Медицинская библиотека · Annals of hematology · 2011

Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.

Troch Marlene, Kiesewetter Barbara, Dolak Werner, Jaeger Ulrich, Püspök Andreas, Müllauer Leonhard, Chott Andreas, Raderer Markus

СтатьяПеревод пока не подготовлен

Аннотация

Mucosa-associated lymphoid tissue (MALT) lymphomas are B cell neoplasms which commonly affect the gastrointestinal (GI) tract. Gastrointestinal MALT lymphomas rarely show plasmacytic differentiation (PCD), and limited data on the potential influence of the anti-CD20 antibody rituximab (R) on PCD exist in the current literature. We have retrospectively analyzed patients with GI MALT lymphomas treated with R-containing regimens because restaging is routinely performed by repeated biopsies with pathohistological response assessment. Twenty-one patients with GI MALT lymphoma were identified to have undergone R-containing therapy. In 19 patients, the lymphoma originated in the stomach, while the colon was the primarily affected organ in two cases. Four patients received R monotherapy and 17 combinations of R with various chemotherapeutic agents. Only two patients with gastric MALT lymphoma had PCD before initiation of therapy. In 7 of 19 patients (37%) without PCD at diagnosis, restaging revealed PCD after or while on treatment with R-containing regimens. Out of these seven patients, only one patient had a complete response as opposed to 10/12 without PCD. These data suggest that R or R-containing treatment regimens may not optimally eradicate the plasma cell component and thus lead to PCD in patients with GI MALT lymphoma. In view of this, rebiopsy and histological re-assessment appear mandatory in patients failing/relapsing after R-containing regimens.

Для цитирования: Troch Marlene, Kiesewetter Barbara, Dolak Werner, Jaeger Ulrich, Püspök Andreas, Müllauer Leonhard, Chott Andreas, Raderer Markus. Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.. Annals of hematology. 2011. DOI: 10.1007/s00277-011-1387-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.